X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 14/Sep 10:02

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

Articles similaires

Monoclonal antibodies: From magic bullet to precision weapon

oncologynews.com.au - 29/Oct 16:57

Monoclonal antibodies (mAbs) prevent, detect, and treat a broad spectrum of non-communicable and infectious diseases. Over the past few years, the...

Unlocking the potential of bispecific ADCs for targeted cancer therapy

oncologynews.com.au - 06/Nov 16:29

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic bullet’ strategy that combines the...

WHO Lists 17 Pathogens That Most Need Vaccines Developed Urgently

thecekodok.com - 06/Nov 19:13

We have just faced a global pandemic that has claimed more than 7 million lives. The Covid-19 disease was only successfully fought after a vaccine was...

Maternal Antibodies Interfere With Malaria Vaccine Efficacy in Infants

medindia.net - 27/Oct 16:38

Maternal antibodies passed across the placenta can hinder the efficacy of malaria vaccines in infants under five months, suggesting adjustments to...

Sorry! Image not available at this time

Immunisation: What you need to know

jamaica-gleaner.com - 11:40

World Immunization Day, observed on November 10 each year, highlights the critical role of vaccines in protecting individuals and communities against...

MPox: Expert advocates investment in vaccine, therapeutic research

veracity.com.ng - 29/Oct 15:23

By: Chidinma Ewunonu-AlukoProf. Simeon Cadmus, a Professor of Veterinary Public Health and Preventive Medicine, University of Ibadan, has called...

Sorry! Image not available at this time

Cancer Research UK & KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into clinical trial

pharmabiz.com - 28/Oct 21:37

Cancer Research UK, one of the world's largest funders of cancer research, and KisoJi Biotechnology Inc., a company focussed on the discovery and...

Sorry! Image not available at this time

COVID-19 and Indigenous peoples’ access to STBBI and related health services: National survey results

ilrtoday.ca - 31/Oct 22:17

Press Release Sexually transmitted and blood-borne Infections (STBBIs) are a public health concern in Canada, with Indigenous populations...

Sorry! Image not available at this time

Merck Announces Emerging Biotech Grant Program Winners

sloveniatimes.com - 01/Nov 07:44

Award recipients to receive in-kind technologies and services to accelerate therapeutics to market Merck experts to provide consultation and training...

Sorry! Image not available at this time

33% of Nigerians Carry Genetic Risk for Kidney Disease: NIH Study Reveals Significant Findings

naija247news.com - 28/Oct 19:32

A groundbreaking study by the National Institutes of Health (NIH) and collaborators has uncovered a major genetic risk factor for kidney disease among...

Les derniers communiqués

  • Aucun élément